Intravascular device administration sets: Replacement after Standard Versus Prolonged use (The RSVP Trial)
Intravascular device administration sets: Replacement after Standard Versus Prolonged use (The RSVP Trial)
批准号:
nhmrc : 1008428
负责人:
A/Pr E Geoffrey Playford
金额:
$107.44万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2011
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2011-01-01 至 2016-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Most hospital patients need an IV drip, a small plastic tube in a vein, often the hand/arm. 14 million/yr are used in Australia. IV drips are connected to plastic tubing through which fluid & medicine is given. IV tubing is needed for a week or more, but is only used for 3-4 days as it was thought this might prevent infection. It is now thought that IV tubing can be used for a week. This would save $1 billion/year & reduce nurses workload. The research will test the safety of this approach.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
What makes sunspots become invasive cancers
-
批准号:nhmrc : GNT1059012
-
项目类别:Project Grants
-
资助金额:$113.0万
-
财政年份:2014
-
负责人:A/Pr E Geoffrey Playford
-
依托单位:
Determinants of progression of actinic keratoses to squamous cancer
-
批准号:nhmrc : 1059012
-
项目类别:Project Grants
-
资助金额:$79.25万
-
财政年份:2014
-
负责人:A/Pr E Geoffrey Playford
-
依托单位:
The SAVE Trial: Securing All intraVenous devices Effectively in hospitals. A randomised controlled trial
-
批准号:nhmrc : 1041910
-
项目类别:Project Grants
-
资助金额:$65.37万
-
财政年份:2013
-
负责人:A/Pr E Geoffrey Playford
-
依托单位:
Safety of Hendra virus anti-G glycoprotein monoclonal antibody in humans
-
批准号:nhmrc : 1041833
-
项目类别:NHMRC Strategic Awards
-
资助金额:$26.67万
-
财政年份:2012
-
负责人:A/Pr E Geoffrey Playford
-
依托单位:
Predicting the risk of invasive candidiasis in critically ill patients
-
批准号:nhmrc : 512307
-
项目类别:NHMRC Project Grants
-
资助金额:$83.9万
-
财政年份:2008
-
负责人:A/Pr E Geoffrey Playford
-
依托单位:
海外基金